SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
209 hedge funds and large institutions have $798M invested in Sorrento Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 85 increasing their positions, 40 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
209
Holders Change
+23
Holders Change %
+12.37%
% of All Funds
4.23%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
58
Increased
85
Reduced
40
Closed
33
Calls
$162M
Puts
$65.6M
Net Calls
+$96.3M
Net Calls Change
+$77.2M
Top Buyers
| 1 |
BlackRock
New York
|
+$27.6M |
| 2 |
Morgan Stanley
New York
|
+$20.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$19.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.9M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$10.3M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$17.3M |
| 2 |
Coatue Management
New York
|
-$6.69M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.58M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.07M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.3M |